Literature DB >> 20070372

A new antibacterial and antioxidant S07-2 compound produced by Bacillus subtilis B38.

Olfa Tabbene1, Ines Karkouch, Salem Elkahoui, Pascal Cosette, Maria-Luisa Mangoni, Thierry Jouenne, Ferid Limam.   

Abstract

An antibacterial compound, S07-2, was purified to homogeneity by hydrophobic interaction, anion exchange, C18 reverse-phase and HS PEG HPLC. The molecular mass of S07-2 was 905.6 Da as determined by MS. The S07-2 compound was resistant to high temperatures (up to 100 degrees C) and could withstand a wide range of pH from 3 to 10. In addition, its antibacterial activity was preserved after treatment with proteases. Biochemical characterization revealed its cyclic peptide structure. This compound showed a bactericidal effect against important food-spoilage bacteria and food-borne pathogens including Listeria monocytogenes and Enterococcus faecalis with lethal concentration values of 62.5 microg mL(-1) and against Salmonella enteritidis at a concentration of 31.25 microg mL(-1). However, no cytotoxic effect against human erythrocytes was recorded. Furthermore, the S07-2 compound displayed a remarkable Fe(2+)-chelating activity (EC(50)=9.76 microg mL(-1)) and 1-diphenyl-2-picrylhydrazyl-scavenging capacity (IC(50)=65 microg mL(-1)). All these chemical and biological features make S07-2 a useful compound in the food industry as a natural preservative.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20070372     DOI: 10.1111/j.1574-6968.2009.01875.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  2 in total

1.  Evaluation of Hypoglycemic and Antioxidant Activities of Soybean Meal Products Fermented by Lactobacillus plantarum FPS 2520 and Bacillus subtilis N1 in Rats Fed with High-Fat Diet.

Authors:  Chung-Hsiung Huang; Chun-Lung Chen; Chen-Che Shieh; Shun-Hsien Chang; Guo-Jane Tsai
Journal:  Metabolites       Date:  2022-05-14

2.  An Antimicrobial Metabolite from Bacillus sp.: Significant Activity Against Pathogenic Bacteria Including Multidrug-Resistant Clinical Strains.

Authors:  Ajay G Chalasani; Gunaseelan Dhanarajan; Sushma Nema; Ramkrishna Sen; Utpal Roy
Journal:  Front Microbiol       Date:  2015-12-15       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.